Physician profile
David Thaler
NPI 1962436873
$163,787.65
in general payments reported to CMS, 2019-2025
23 companies · $49K in 2025
The $49K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,404 · 2020: $8,935 · 2021: $14K · 2022: $21K · 2023: $25K · 2024: $36K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $110K · Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $109,922.50 |
| Food and Beverage | $131.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $136,272.77 | 2020-2025 | |
| Abbott Laboratories | $16,496.00 | 2019-2024 | Amplatzer Amulet, Amplatzer Talisman, Jeti All In One Non-Sterile Kit |
| Pfizer INC. | $7,175.81 | 2019 | |
| Magenta Medical INC | $2,300.00 | 2025 | |
| Sunovion Pharmaceuticals INC. | $577.49 | 2019-2020 | |
| Biogen, INC. | $162.78 | 2019-2020 | |
| Shockwave Medical, INC | $131.13 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ucb, INC. | $125.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $79.96 | 2019 | |
| Amneal Pharmaceuticals LLC | $77.94 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $75.04 | 2019-2020 | |
| Allergan, INC. | $66.28 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $66.18 | 2019 | |
| Acorda Therapeutics, INC | $48.34 | 2019 | |
| Csl Behring | $43.49 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.80 | 2019 | |
| Boston Scientific Corporation | $20.72 | 2019 | |
| Avanir Pharmaceuticals, INC. | $17.25 | 2019 | |
| Emd Serono, INC. | $17.17 | 2020 | |
| Novocure INC. | $12.06 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thaler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.